Home › Compare › LXXGF vs EQR

LXXGF vs EQR: Dividend Comparison 2026

LXXGF yields 2481.39% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LXXGF wins by $75119324141.87M in total portfolio value
10 years
LXXGF
LXXGF
● Live price
2481.39%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$75119324141.92M
Annual income
$69,601,575,725,367,330.00
Full LXXGF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — LXXGF vs EQR

📍 LXXGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLXXGFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LXXGF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LXXGF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LXXGF
Annual income on $10K today (after 15% tax)
$210,918.11/yr
After 10yr DRIP, annual income (after tax)
$59,161,339,366,562,220.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, LXXGF beats the other by $59,161,339,366,557,570.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LXXGF + EQR for your $10,000?

LXXGF: 50%EQR: 50%
100% EQR50/50100% LXXGF
Portfolio after 10yr
$37559662070.98M
Annual income
$34,800,787,862,686,400.00/yr
Blended yield
92.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

LXXGF
No analyst data
Altman Z
3102.3
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LXXGF buys
0
EQR buys
0
No recent congressional trades found for LXXGF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLXXGFEQR
Forward yield2481.39% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$75119324141.92M ✓$47.8K
Annual income after 10y$69,601,575,725,367,330.00 ✓$5,475.61
Total dividends collected$74733586285.14M ✓$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: LXXGF vs EQR ($10,000, DRIP)

YearLXXGF PortfolioLXXGF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$258,839$248,138.96$11,380$679.82+$247.5K → LXXGF
2$6,279,577$6,002,619.55$13,014$837.25+$6.27M → LXXGF
3$142,819,047$136,099,899.71$14,961$1,036.20+$142.80M → LXXGF
4$3,045,691,942$2,892,875,561.63$17,297$1,289.22+$3045.67M → LXXGF
5$60,915,064,079$57,656,173,701.07$20,121$1,613.15+$60915.04M → LXXGF
6$1,142,886,285,089$1,077,707,166,524.28$23,561$2,030.84+$1142886.26M → LXXGF
7$20,119,994,746,279$18,897,106,421,233.41$27,783$2,573.54+$20119994.72M → LXXGF
8$332,439,598,720,068$310,911,204,341,549.80$33,013$3,284.39+$332439598.69M → LXXGF
9$5,156,774,221,077,804$4,801,063,850,447,331.00$39,547$4,223.51+$5156774221.04M → LXXGF
10$75,119,324,141,920,580$69,601,575,725,367,330.00$47,791$5,475.61+$75119324141.87M → LXXGF

LXXGF vs EQR: Complete Analysis 2026

LXXGF — Stock

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts.

Full LXXGF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this LXXGF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LXXGF vs SCHDLXXGF vs JEPILXXGF vs OLXXGF vs KOLXXGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.